Acutaas opens HPAPI pilot plant
Submitted by:
Andrew Warmington
India’s Acutaas Chemicals, the former Ami Organics, has inaugurated a new pilot plant at its
PharmaBlock opens OPC R&D centre
Submitted by:
Andrew Warmington
China’s PharmaBlock has officially inaugurated its new Oligonucleotide, Peptide and Conjugates (OPC) R&D centre in
Curia to scale NCT process
Submitted by:
Andrew Warmington
ExoZymes, which develops AI-enhanced enzymes that transform abundant feedstock into nutraceuticals and novel medicines, will
First peptide module opens
Submitted by:
Andrew Warmington
The first of four scheduled modules has begun operations at Neuland Laboratories’ commercial-scale peptide manufacturing site
Axplora expands in India
Submitted by:
Andrew Warmington
Axplora has announced a “significant” investment at its site in Vizag, India (pictured)
Esteve acquires Regis
Submitted by:
Andrew Warmington
Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago
Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago, and
Ofichem buys site in Sweden
Submitted by:
Andrew Warmington
Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which
Axplora to further expand Farmabios
Submitted by:
Andrew Warmington
Axplora is to invest a further €35 million to expand its Farmabios site in Gropello
Nucleic acid API boost
Submitted by:
Andrew Warmington
Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install
Flamma opens in China
Submitted by:
Andrew Warmington
Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where